COMMUNITY HEALTH SYSTEMS INC CYH Cash Flow

Community health systems inc (CYH)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Cash flows from operating activities:
Net income (loss)
34,000	-346,000	2,000	-145,000	-101,000	-299,000	-307,000	-92,000	-6,000	-2,006,000	-91,000	-122,000	-177,000	-199,000	-56,000	-1,407,000	36,000	-49,000	76,000	133,000	99,000	136,000	94,000	71,000	-98,000	52,000	22,000	47,000	96,000	85,823	58,758	102,167	99,252	53,120	92,631	53,547	78,325	92,249	84,854	86,342	84,996
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
144,000	152,000	151,000	152,000	153,000	169,000	173,000	177,000	181,000	196,000	207,000	222,000	236,000	261,000	265,000	276,000	298,000	298,000	288,000	292,000	296,000	290,000	280,000	315,000	302,000	200,000	196,000	195,000	192,000	189,638	182,207	179,801	174,354	171,748	161,550	163,049	161,318	157,660	151,119	153,381	147,679
Deferred income taxes
-184,000	-	-	-	6,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Government and other legal settlements and related costs
2,000	26,000	16,000	4,000	5,000	2,000	2,000	2,000	5,000	1,000	2,000	7,000	-1,000	-	-	-	-	3,000	0	-7,000	8,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
2,000	2,000	2,000	3,000	3,000	3,000	3,000	3,000	4,000	4,000	5,000	6,000	9,000	10,000	10,000	12,000	14,000	15,000	14,000	16,000	14,000	18,000	14,000	11,000	11,000	9,000	10,000	9,000	10,000	10,292	10,084	10,129	10,495	10,954	10,856	10,814	9,918	8,880	9,481	10,655	9,763
Loss on sale, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-3,000	0	-1,000	-	-	-	-	-	-	-	-	-	-	-	-	728	-66	0	-3,234	-	-	-	-
Impairment of hospitals sold or held for sale
-	-	-	-	-	-	-	-	-	-	-	-	-	7,000	0	0	1,000	-3,000	6,000	0	2,000	-	-	-	-	-	-	-	-	-	-	-	-	0	0	39,562	8,368	-	-	-	-
Impairment and loss on sale of businesses, net
45,000	68,000	-1,000	33,000	38,000	354,000	112,000	174,000	28,000	1,760,000	33,000	80,000	250,000	224,000	39,000	1,639,000	17,000	-	-	-	-	-5,000	0	4,000	42,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from early extinguishment of debt
-4,000	-23,000	0	0	-31,000	-1,000	-27,000	63,000	-4,000	-5,000	-4,000	-10,000	-21,000	-	-	-	-	0	0	-8,000	-8,000	0	0	0	-73,000	0	0	0	-1,000	453	-52,024	0	-63,429	-	-	-	0	-	-	-	-
Excess tax benefit relating to stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	0	3,000	0	1,000	1,000	5,000	2,455	508	33	1,004	674	-43	-16	4,675	110	5	5,755	4,349
Other non-cash expenses, net
-49,000	-42,000	-39,000	-65,000	-36,000	-13,000	-2,000	-11,000	-12,000	-11,000	-6,000	-10,000	-8,000	-12,000	3,000	-8,000	-14,000	-25,000	-23,000	-6,000	7,000	21,000	-15,000	-13,000	-6,000	-109,000	21,000	21,000	6,000	10,518	6,021	13,892	2,569	14,437	9,966	15,486	-11,173	4,266	10,579	1,615	-3,957
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable
-158,000	-11,000	-89,000	-3,000	10,000	7,000	-59,000	-45,000	66,000	-503,000	-43,000	-175,000	-11,000	56,000	0	-69,000	109,000	-72,000	203,000	-114,000	202,000	7,000	133,000	-5,000	171,000	54,000	125,000	-42,000	148,000	-23,814	28,431	35,899	163,484	47,527	7,723	26,628	56,454	1,470	-38,317	-30,308	94,204
Supplies, prepaid expenses and other current assets
53,000	2,000	32,000	-58,000	-14,000	-2,000	-29,000	-6,000	21,000	-4,000	-18,000	-12,000	67,000	39,000	-33,000	-45,000	14,000	-4,000	42,000	44,000	-14,000	-67,000	77,000	-24,000	-14,000	-52,000	75,000	-17,000	2,000	30,753	28,327	-85,191	125,111	11,403	40,829	4,962	-14,336	44,659	-5,902	-5,761	6,908
Accounts payable, accrued liabilities and income taxes
-78,000	158,000	-342,000	10,000	17,000	-116,000	261,000	-275,000	-33,000	146,000	-89,000	-112,000	-14,000	119,000	-44,000	-276,000	64,000	-239,000	-1,000	46,000	-284,000	336,000	-134,000	28,000	-83,000	282,000	-26,000	-82,000	-98,000	142,844	51,313	-44,266	96,109	99,944	16,648	144,456	-14,938	-10,735	58,587	-53,370	167,470
Other
66,000	143,000	-2,000	45,000	59,000	19,000	15,000	0	2,000	14,000	25,000	32,000	34,000	-98,000	75,000	-35,000	27,000	-9,000	47,000	5,000	10,000	23,000	10,000	22,000	28,000	-4,000	-12,000	-4,000	-5,000	-9,867	8,203	15,365	-30,701	21,249	7,658	-1,834	748	13,098	2,249	-13,495	1,130
Net cash provided by operating activities
57,000	194,000	-74,000	132,000	133,000	-166,000	346,000	-12,000	106,000	156,000	114,000	261,000	242,000	327,000	178,000	338,000	294,000	306,000	111,000	565,000	-61,000	976,000	125,000	449,000	65,000	648,000	132,000	252,000	57,000	502,135	294,938	295,617	187,310	441,673	235,550	397,174	187,511	290,353	356,585	242,432	299,360
Cash flows from investing activities:
Acquisitions of facilities and other related businesses
-	0	0	9,000	4,000	5,000	11,000	2,000	8,000	2,000	0	2,000	2,000	1,000	8,000	15,000	99,000	16,000	14,000	14,000	13,000	50,000	0	267,000	2,774,000	10,000	24,000	5,000	5,000	9,073	67,700	-3,209	248,436	205,909	5,187	158,842	45,422	180,710	65,128	2,233	180
Purchases of property and equipment
99,000	116,000	110,000	91,000	121,000	114,000	118,000	125,000	170,000	136,000	154,000	128,000	146,000	183,000	154,000	183,000	224,000	257,000	222,000	233,000	241,000	293,000	199,000	180,000	181,000	193,000	126,000	182,000	113,000	211,531	171,008	201,558	184,903	243,868	181,462	197,508	153,875	285,525	117,929	137,371	126,553
Proceeds from disposition of hospitals and other ancillary operations
2,000	241,000	202,000	0	161,000	177,000	140,000	77,000	11,000	-	-	-	-	131,000	0	0	12,000	68,000	25,000	0	62,000	-	-	-	-	-	-	-	-	-	-	-	-	809	154,114	3,881	14,583	-	-	-	-
Proceeds from sale of property and equipment
-	-	-	-	-	1,000	3,000	1,000	3,000	-	-	-	-	5,000	3,000	3,000	4,000	2,000	2,000	8,000	3,000	-	-	-	-	3,000	2,000	1,000	1,000	1,192	1,371	2,689	748	1,909	1,217	447	7,587	5,556	538	1,961	346
Purchases of available-for-sale debt securities and equity securities
17,000	22,000	19,000	24,000	15,000	28,000	12,000	19,000	19,000	40,000	48,000	25,000	12,000	110,000	332,000	26,000	37,000	35,000	37,000	31,000	59,000	65,000	61,000	59,000	78,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of available-for-sale debt securities and equity securities
21,000	20,000	20,000	20,000	32,000	39,000	12,000	29,000	34,000	75,000	86,000	21,000	26,000	78,000	153,000	193,000	40,000	33,000	37,000	30,000	56,000	38,000	68,000	47,000	76,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase in other investments
16,000	24,000	49,000	63,000	34,000	65,000	23,000	25,000	28,000	48,000	35,000	23,000	37,000	41,000	88,000	46,000	67,000	69,000	56,000	41,000	39,000	124,000	136,000	152,000	99,000	106,000	99,000	66,000	69,000	75,836	59,848	94,608	67,708	57,269	55,769	42,934	32,277	38,580	34,244	27,267	36,991
Net cash (used in) provided by investing activities
-109,000	101,000	44,000	-166,000	19,000	5,000	-9,000	-64,000	-177,000	-122,000	595,000	767,000	-171,000	-121,000	-426,000	1,548,000	-371,000	-274,000	-265,000	-281,000	-231,000	-408,000	-291,000	-596,000	-3,056,000	-306,000	-247,000	-252,000	-186,000	-295,248	-297,185	-290,268	-500,299	-504,328	-87,087	-394,956	-209,404	-499,259	-216,763	-164,910	-163,378
Cash flows from financing activities:
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	2,000	5,000	17,000	23,000	28,000	8,000	6,000	1,000	5,000	32,000	72,000	14,250	4,481	961	308	30	49	706	18,125	3,077	224	29,608	24,007
Repurchase of restricted stock shares for payroll tax withholding requirements
1,000	0	0	0	1,000	0	0	0	1,000	0	0	0	5,000	1,000	0	-2,000	7,000	0	0	0	20,000	0	0	0	11,000	0	0	1,000	14,000	-165	91	42	9,032	-	-	-	-	-	-	-	-
Stock buy-back
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	8,000	19,000	-	-	-	-	-	-	-	-	6,029	95,690	12,202	40
Deferred financing costs and other debt-related costs
32,000	18,000	0	3,000	25,000	3,000	39,000	43,000	11,000	0	4,000	22,000	40,000	-	-	-	-	0	0	10,000	20,000	4,000	3,000	0	269,000	0	12,000	0	1,000	5,353	71,661	39,199	24,787	-	-	-	-	-	-	-	-
Excess tax benefit relating to stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	0	3,000	0	1,000	1,000	5,000	2,455	508	33	1,004	674	-43	-16	4,675	110	5	5,755	4,349
Proceeds from noncontrolling investors in joint ventures
-	0	8,000	1,000	1,000	-	-	-	-	0	0	0	5,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	366	0	863	2,046	0	3,900	1,255
Redemption of noncontrolling investments in joint ventures
2,000	5,000	4,000	1,000	1,000	4,000	21,000	3,000	3,000	1,000	1,000	0	4,000	0	3,000	0	16,000	18,000	4,000	7,000	7,000	150,000	2,000	1,000	5,000	-	-	-	-	4,291	3,821	4,792	31,096	8,238	1,481	3,078	225	-	-	-	-
Distributions to noncontrolling investors in joint ventures
30,000	21,000	21,000	30,000	27,000	22,000	22,000	29,000	23,000	21,000	26,000	25,000	28,000	23,000	22,000	29,000	18,000	31,000	21,000	25,000	23,000	30,000	30,000	25,000	19,000	16,000	22,000	23,000	15,000	7,324	26,086	7,552	27,038	6,166	19,850	14,745	15,333	26,243	12,499	12,497	16,874
Proceeds from sale-lease back
2,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other borrowings
14,000	-	-	-	12,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Borrowings under credit agreements
-	-	-	-	-	4,000	-2,000	16,000	10,000	2,000	-1,000	230,000	610,000	950,000	1,123,000	1,242,000	1,564,000	1,458,000	1,079,000	1,134,000	1,251,000	783,000	860,000	409,000	7,079,000	380,000	518,000	195,000	101,000	1,601	340,810	929,252	2,704,337	-	-	-	0	-	-	-	-
Issuance of long-term debt
1,462,000	553,000	455,000	194,000	1,840,000	-	-	-	-	0	0	900,000	2,200,000	-	-	-	-	-	-	-	-	0	0	0	4,000,000	-	-	-	-	0	2,800,000	0	1,025,000	-	-	-	0	-	-	-	-
Proceeds from ABL facility
540,000	177,000	0	0	25,000	210,000	0	538,000	49,000	79,000	0	0	26,000	41,000	35,000	0	31,000	94,000	21,000	16,000	75,000	0	71,000	0	133,000	18,000	20,000	0	300,000	50,000	0	0	300,000	-	-	-	0	-	-	-	-
Repayments of long-term indebtedness
1,871,000	937,000	517,000	208,000	1,895,000	164,000	1,160,000	620,000	89,000	120,000	855,000	1,590,000	2,826,000	1,223,000	1,213,000	2,799,000	1,480,000	1,426,000	1,102,000	1,254,000	1,268,000	889,000	927,000	478,000	7,686,000	493,000	496,000	230,000	403,000	88,640	2,916,250	898,836	3,626,274	1,522,765	99,970	14,133	14,665	14,524	12,795	21,003	13,154
Net cash provided by (used in) financing activities
82,000	-236,000	-20,000	-36,000	-71,000	22,000	-210,000	-140,000	-68,000	-61,000	-887,000	-507,000	-62,000	-101,000	-80,000	-1,606,000	74,000	-34,000	-25,000	-141,000	5,000	-280,000	-2,000	-77,000	3,231,000	-	-	-34,000	26,000	-59,672	127,788	-19,538	312,422	-73,792	-73,583	-81,502	-6,560	-59,674	-120,827	-8,834	-457
Net change in cash and cash equivalents
30,000	59,000	-50,000	-70,000	81,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash and cash equivalents
-	-	-	-	-	-	-	-	-139,000	-	-178,000	521,000	9,000	105,000	-328,000	280,000	-3,000	-2,000	-179,000	143,000	-287,000	288,000	-168,000	-224,000	240,000	229,000	-107,000	-34,000	-103,000	147,215	125,541	-14,189	-567	-136,447	74,880	-79,284	-28,453	-268,580	18,995	68,688	135,525
Supplemental disclosure of cash flow information:
Interest payments
264,000	201,000	492,000	129,000	189,000	299,000	151,000	274,000	212,000	222,000	221,000	130,000	279,000	163,000	278,000	182,000	307,000	173,000	293,000	159,000	300,000	170,000	309,000	177,000	175,000	137,000	150,000	146,000	150,000	132,396	130,443	170,021	161,140	132,345	220,642	101,593	226,124	101,259	229,303	99,948	220,202
Income tax refunds (payments), net
2,000	-	-	-	-	-	-	-	-	-9,000	-1,000	6,000	0	10,000	2,000	4,000	0	2,000	1,000	8,000	1,000	-91,000	-16,000	6,000	-79,000	1,000	2,000	69,000	1,000	596	33,376	22,089	-61	29,171	22,989	-26,374	677	-739	49,214	78,777	934